We are live on ! Find out more
RLYB icon

Rallybio
RLYB

47 hedge funds and large institutions have $194M invested in Rallybio in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 8

24% more funds holding

Funds holding: 38 → 47 (+9)

0.14% more ownership

Funds ownership: 10.67% → 10.81% (+0.14%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

25% less capital invested

Capital invested by funds: $260M → $194M (-$66.2M)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.74%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
11
Increased
16
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NHAS
Novo Holdings A/S
Denmark
+$4.51M
2
BlackRock
BlackRock
New York
+$4.41M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$4.04M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.09M
5
State Street
State Street
Massachusetts
+$877K

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$8.62M
2
JP Morgan Chase
JP Morgan Chase
New York
-$3.27M
3
5VM
5AM Venture Management
California
-$2.17M
4
TCM
Tekla Capital Management
Massachusetts
-$1.18M
5
UBS Group
UBS Group
Switzerland
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$29.3M – – –
5VM
2
5AM Venture Management
California
$27.8M -$2.17M -26,250 -5%
TGA
3
TPG GP A
Texas
$21.1M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$20.2M +$34.6K +418 +0.1%
CPX
5
Canaan Partners XI
California
$16.8M – – –
NLVP
6
New Leaf Venture Partners
New York
$16.1M – – –
PBPIA
7
Pivotal bioVenture Partners Investment Advisor
California
$15.9M – – –
TCM
8
Tekla Capital Management
Massachusetts
$15.3M -$1.18M -14,208 -5%
BlackRock
9
BlackRock
New York
$6.34M +$4.41M +53,332 +89%
AIIC
10
AJU IB Investment Company
South Korea
$5.27M – – –
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.96M +$4.04M +48,771 +122%
NHAS
12
Novo Holdings A/S
Denmark
$3.04M +$4.51M +54,493 New
LCM
13
Laurion Capital Management
New York
$2.79M – – –
SAM
14
Sectoral Asset Management
Quebec, Canada
$2.69M +$867K +10,481 +28%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.53M +$1.09M +13,124 +92%
State Street
16
State Street
Massachusetts
$1.11M +$877K +10,594 +115%
Northern Trust
17
Northern Trust
Illinois
$917K +$723K +8,733 +113%
Walleye Capital
18
Walleye Capital
New York
$416K +$616K +7,443 New
Renaissance Technologies
19
Renaissance Technologies
New York
$368K +$545K +6,589 New
Charles Schwab
20
Charles Schwab
California
$319K +$305K +3,688 +183%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$291K +$256K +3,089 +146%
N
22
Nuveen
North Carolina
$199K +$267K +3,224 New
Millennium Management
23
Millennium Management
New York
$175K +$259K +3,136 New
JF
24
Jump Financial
Illinois
$145K +$215K +2,600 New
TI
25
Trexquant Investment
Connecticut
$110K +$163K +1,975 New
1
2

RLYB Hedge Fund Activity: Q1 2022 in Review

47 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q1 2022, worth a combined $194M — down 25% from $260M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RLYB positions and 2 closed out — a net gain of 9 holders — while 16 added to existing stakes and 8 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $4.51M. The largest seller was HHLR Advisors, exiting entirely with an estimated $8.62M sold.

  • 47 institutional investors held Rallybio (RLYB) as of Q1 2022, up from 38 in Q4 2021.
  • Funds reported $194M of Rallybio stock for Q1 2022, down 25% quarter-over-quarter.
  • 11 funds opened new Rallybio positions in Q1 2022 and 2 closed out, a net change of +9 holders.
  • The largest Rallybio buyer in Q1 2022 was Novo Holdings A/S, an estimated $4.51M added.
  • The largest Rallybio seller in Q1 2022 was HHLR Advisors, an estimated $8.62M sold.

Based on aggregated 13F filings for Q1 2022.